Skip to content
Back to search results

FRAIL Frailty Scale

Introduced by
John E. Morley
Year
2012
Type
Clinician-administered questionnaire
Family
frailty-phenotype
Font size

What does it do?

The FRAIL Scale is a brief, five-item clinical screening tool developed by John E. Morley and colleagues to identify frailty in older adults.

Designed as a simple and efficient alternative to more comprehensive frailty assessments, it incorporates the key domains of the frailty phenotype: fatigue, resistance, ambulation, illness, and weight loss. The FRAIL Scale is widely used in primary care, hospital, and long-term care settings to stratify risk and guide management decisions.

The intuition behind the method

Frailty is a geriatric syndrome characterized by diminished physiological reserve and increased vulnerability to stressors, leading to adverse health outcomes including falls, hospitalization, and mortality. The FRAIL Scale operationalizes frailty through five practical domains that capture the core elements of the phenotype: lack of energy and motivation (fatigue), inability to climb stairs or walk (ambulation), reduced ability to recover from illness (resistance), accumulation of medical problems (illness burden), and unintentional weight loss (nutritional decline). These five items reflect a balance between clinical comprehensiveness and practical brevity, enabling rapid screening in busy clinical settings.

History

The FRAIL Scale was developed by John E. Morley and colleagues in response to the need for a brief, validated screening tool for frailty that could be widely adopted in primary care and acute settings. First published in the Journal of the American Medical Directors Association in 2012, it was designed to operationalize the frailty phenotype model developed by Fried and colleagues (2001) while maintaining practicality for busy clinicians. The scale has since been adopted internationally, translated into multiple languages, and validated in diverse populations including hospitalized patients, nursing home residents, and community-dwelling older adults. It remains one of the most widely used frailty screening instruments in clinical practice.

When to use it

The FRAIL Scale is used in primary care clinics, hospital wards, emergency departments, and long-term care facilities as a rapid first-line screening tool for frailty. Administer it to older adults aged 65 and above, particularly those presenting with non-specific symptoms (falls, functional decline, cognitive impairment) or multiple comorbidities. Use the FRAIL Scale when (1) quick risk stratification is needed to guide triage or intervention, (2) identifying candidates for comprehensive geriatric assessment or multidisciplinary intervention, (3) screening hospitalized older patients to predict length of stay and discharge planning, (4) monitoring response to frailty interventions, or (5) population-level frailty screening in primary care. It is suitable for brief encounters where detailed assessment is not feasible.

Limitations and considerations

  • Limited validation in non-Western populations: most validation data come from North American and European cohorts; applicability to other regions may be limited.
  • Subjective and recall-dependent items: fatigue and weight loss rely on subjective report and 3-month recall, introducing potential for underreporting or overestimation.
  • Modest diagnostic accuracy: sensitivity and specificity are moderate compared to comprehensive frailty assessments; it is best viewed as a screening rather than definitive diagnostic tool.
  • Does not distinguish functional limitation from frailty: a person with functional impairment due to chronic disease may score high without meeting physiological frailty criteria.
  • Missing objective measures: absence of objectively timed performance tests (e.g., gait speed, grip strength) compared to other frailty phenotype measures.

Source conditions do not replace independent scientific review or validation by an analysis engine.

Strengths

  • Brevity and simplicity: five items requiring <2 minutes of administration time and no special equipment, making it highly feasible for use in busy clinical settings and primary care.
  • Incorporates core frailty domains: captures the essential phenotypic components (fatigue, mobility, resistance, illness, weight loss) without excessive redundancy.
  • Clinical relevance: all five items are clinically meaningful and address domains modifiable by intervention; weight loss and fatigue are actionable targets.
  • Population validity: developed and validated across diverse community-dwelling and hospitalized older adult populations, with reproducible predictive validity.
  • Strong prognostic utility: frailty status predicts hospitalization, disability, institutionalization, and mortality, with high positive predictive value for adverse outcomes.

Applications

  • Rapid frailty screening in primary care: identification of at-risk older adults during routine office visits to triage for comprehensive assessment or preventive intervention.
  • Hospital admission risk stratification: assessment of frailty status upon hospital admission to predict length of stay, need for intensive services, and discharge planning requirements.
  • Post-acute care planning: evaluation of frailty in hospitalized or transitioning older adults to inform safe discharge planning and identification of those requiring intensive rehabilitation or institutional care.
  • Preventive medicine and intervention targeting: identification of pre-frail individuals (score 1-2) for structured exercise, nutritional, and psychosocial interventions to prevent progression to clinical frailty.
  • Outcomes research and population health: large-scale screening and frailty prevalence estimation to guide resource allocation and population-level prevention strategies in aging communities.

How it works

How it works

1

The FRAIL Scale is administered as a structured interview by a healthcare provider (physician, nurse, or trained clinician). The clinician asks the patient five yes/no questions: (1) 'In the last 3 months, have you had fatigue or low energy that prevented you from doing the things you wanted to do?', (2) 'Do you have resistance (difficulty) in walking up one flight of stairs or in walking 100 meters on level ground?', (3) 'In the last 3 months, have you had an illness that caused you to reduce or lose your ability to do activities?', (4) 'Do you currently take more than 5 prescription medications?', and (5) 'Have you lost more than 5% of your body weight in the last 3 months without trying?' Each question is answered yes (1 point) or no (0 points). Administration takes less than 2 minutes and requires no special equipment or training beyond standard clinical interviewing.

2

Each of the five items is scored 0 or 1 point. The total FRAIL score ranges from 0 to 5. Items are summed without weighting or transformation. A score of 0 indicates no frailty; a score of 1-2 indicates pre-frailty; a score of 3-5 indicates frailty. The scale produces three mutually exclusive categories that form a frailty continuum from robust health to clinical frailty.

3

A FRAIL score of 0 indicates a robust or non-frail older adult with good functional capacity and low risk of adverse outcomes. A FRAIL score of 1-2 indicates pre-frailty: the individual shows early signs of frailty (fatigue, weight loss, or reduced activity tolerance) but does not yet meet criteria for full frailty; these individuals are at intermediate risk for progression to frailty and benefit from preventive interventions. A FRAIL score of 3-5 indicates clinical frailty: the individual meets criteria for the frailty phenotype and is at high risk for falls, hospitalization, disability, loss of independence, and mortality. Scores ≥3 warrant comprehensive geriatric assessment and intensive intervention to prevent or slow further decline.

Common pitfalls

  • Assuming a score of 0 means 'healthy': a FRAIL score of 0 indicates absence of frailty but does not rule out significant comorbidity, functional limitation, or disability from other causes.
  • Applying uniform cutoffs across age groups: a score of 2 may have different prognostic meaning in a 75-year-old versus an 85-year-old; age-stratified interpretation may be more appropriate.
  • Relying solely on FRAIL without comprehensive assessment: the FRAIL Scale identifies frailty but does not address underlying causes, comorbidities, or cognitive/mental health factors that require separate evaluation.
  • Misinterpreting 'pre-frailty': scores of 1-2 should not be dismissed as unimportant; pre-frail individuals are at substantial risk for progression and are appropriate candidates for prevention programs.

Frequently asked questions

What is the difference between pre-frailty (score 1-2) and frailty (score 3-5), and why does it matter clinically?

Pre-frail individuals (score 1-2) show early signs of frailty and are at intermediate risk for future disability and mortality, but have not yet developed the full phenotype. This group is the primary target for preventive interventions (exercise, nutrition optimization, social engagement) that can reverse decline or prevent progression to clinical frailty. Frail individuals (score ≥3) require more intensive, multidisciplinary management including comprehensive assessment of underlying causes and potentially more aggressive medical optimization.

Should objective weight loss be verified by reviewing medical records, or is patient report acceptable?

Patient report of unintentional weight loss is used for screening; however, if weight loss is a key clinical concern or if the patient's report is unreliable, review of recent clinic visit weights or asking about changes in clothing fit can provide corroboration. Documentation in the medical record is ideal but not required for FRAIL scoring; the tool is designed for rapid clinical assessment using available history.

How does a FRAIL score relate to biological frailty markers such as grip strength or gait speed?

The FRAIL Scale captures the clinical phenotype of frailty through self-reported and observable domains, but does not include objective performance measures. It correlates with grip strength, gait speed, and physical activity level but is not a substitute for performance-based assessment. Ideally, FRAIL screening is combined with objective measures such as the Short Physical Performance Battery for comprehensive frailty phenotyping.

Can the FRAIL Scale be used in individuals with cognitive impairment or dementia?

The FRAIL Scale relies on accurate patient history and self-report. In moderate to severe cognitive impairment, responses may be unreliable. In mild cognitive impairment, collateral history from a caregiver can supplement patient report. For individuals with significant dementia, informant-based assessment or objective measures (weight trends, medication review) may be more reliable than direct patient questioning.

Related methods

Sources

  1. Morley, J. E., Vellas, B., van Kan, G. A., et al. (2013). Frailty consensus: a call to action. J Am Med Dir Assoc, 14(6), 392-397.

    Open DOI reference
    Copied.
  2. Abellan van Kan, G., Rolland, Y., Bergman, H., et al. (2008). The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging, 12(1), 29-37.

    Open DOI reference
    Copied.
  3. Morley, J. E., Haren, M. T., Rolland, Y., & Kim, M. J. (2012). Frailty. Med Clin North Am, 96(2), 395-399.

    Open publication reference
    Copied.